The Annual Meeting of the European Heart Rhythm Association (EHRA 2023)

Barcelona 16 April 2023 - 18 April 2023

Single-lead ECGs may not be as accurate in detecting AF as previously thought

04 May 2023 by

A new study has challenged previously reported accuracy of atrial fibrillation (AF) detection with single-lead electrocardiograms (ECGs) technology.

Single-lead ECGs may not be as accurate in detecting AF as previously thought

04 May 2023

NOACs proven safe, effective in Asians with AF

03 May 2023 by

Use of nonvitamin K antagonist oral anticoagulants (NOACs) helps prevent thromboembolic events in Asian patients with atrial fibrillation (AF), with fewer bleeding events relative to warfarin therapy, according to the results of a study presented at the recent EHRA 2023.

NOACs proven safe, effective in Asians with AF

03 May 2023

Micra implant a viable substitute to pacemakers

02 May 2023 by

The Micra Transcatheter Pacing System (M-TPS) can be a safe and effective substitute to a conventional pacemaker, suggests a study presented at the recent EHRA 2023. M-TPS has a surgically created subcutaneous pocket and no transvenous leads, which help prevent complications.

Micra implant a viable substitute to pacemakers

02 May 2023

Extended vs standard ECG monitoring detects more arrhythmias in HCM

02 May 2023 by

Extended ECG monitoring for 30 days significantly increases the detection rates of arrhythmias compared with the standard 24-hour monitoring period in patients with hypertrophic cardiomyopathy (HCM), according to the TEMPO-HCM study presented at EHRA 2023.

Extended vs standard ECG monitoring detects more arrhythmias in HCM

02 May 2023

Antiarrhythmic drugs cut atrial high-rates episode burden, AF risk

01 May 2023 by

Individuals with atrial high-rates episodes (AHREs) are at greater risk of progression to atrial fibrillation (AF). But the good news is that treatment with antiarrhythmic medication appears to have a protective effect both on AHRE burden and AF risk.

Antiarrhythmic drugs cut atrial high-rates episode burden, AF risk

01 May 2023

AF screening tied to reduction in stroke risk in patients with high NT-proBNP

26 Apr 2023 by

Screening for atrial fibrillation (AF) is associated with a reduction in the risk of stroke in individuals with a high NT-proBNP* level, according to a post hoc analysis of the LOOP study.

AF screening tied to reduction in stroke risk in patients with high NT-proBNP

26 Apr 2023

Statin use tied to lower stroke risk in patients with AF

25 Apr 2023 by

Among patients with atrial fibrillation (AF), statin use was associated with a significantly lower risk of stroke or transient ischaemic attack (TIA) compared with non-use, according to a study presented at EHRA 2023.

Statin use tied to lower stroke risk in patients with AF

25 Apr 2023

Novel ablation strategy superior to PVI for persistent AF

25 Apr 2023 by

A three-step ablation strategy that systematically targets multiple proarrhythmogenic atrial structures appeared superior to pulmonary vein isolation (PVI) alone in patients with persistent atrial fibrillation (AF), according to 10-month results of a new study presented at EHRA 2023.

Novel ablation strategy superior to PVI for persistent AF

25 Apr 2023

Ventricular tachycardia may predict death in non-ischaemic cardiomyopathy patients

24 Apr 2023 by

Ventricular tachycardia predicts all-cause death and non-sudden cardiovascular death (NSCVD) in patients with non-ischaemic cardiomyopathy, a study suggests.

Ventricular tachycardia may predict death in non-ischaemic cardiomyopathy patients

24 Apr 2023

Severe COVID patients 16 times more likely to experience V-tach

24 Apr 2023 by

Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia (V-tach) within 6 months following discharge compared with matched controls without severe infection in a Swedish case-control study presented at EHRA 2023.

Severe COVID patients 16 times more likely to experience V-tach

24 Apr 2023